DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▼ | UniProt ID |
---|---|---|---|---|---|
C0026707 | Mucopolysaccharidosis IV | GNPTG | 84572 | N-acetylglucosamine-1-phosphate transferase subunit gamma | Q9UJJ9 |
C0013336 | Dwarfism | GNPTG | 84572 | N-acetylglucosamine-1-phosphate transferase subunit gamma | Q9UJJ9 |
C0035334 | Retinitis Pigmentosa | GNPTG | 84572 | N-acetylglucosamine-1-phosphate transferase subunit gamma | Q9UJJ9 |
C0476254 | Dyslexia | GNPTG | 84572 | N-acetylglucosamine-1-phosphate transferase subunit gamma | Q9UJJ9 |
C2673377 | MUCOLIPIDOSIS II ALPHA/BETA (disorder) | GNPTG | 84572 | N-acetylglucosamine-1-phosphate transferase subunit gamma | Q9UJJ9 |
C0003507 | Aortic Valve Stenosis | GNPTG | 84572 | N-acetylglucosamine-1-phosphate transferase subunit gamma | Q9UJJ9 |
C0086795 | Pfaundler-Hurler Syndrome | GNPTG | 84572 | N-acetylglucosamine-1-phosphate transferase subunit gamma | Q9UJJ9 |
C0376358 | Malignant neoplasm of prostate | NAGK | 55577 | N-acetylglucosamine kinase | Q9UJ70 |
C0033578 | Prostatic Neoplasms | NAGK | 55577 | N-acetylglucosamine kinase | Q9UJ70 |
C0004352 | Autistic Disorder | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0086648 | MPS III B | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0699791 | Stomach Carcinoma | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C1565489 | Renal Insufficiency | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0026706 | Mucopolysaccharidosis III | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0004153 | Atherosclerosis | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0026703 | Mucopolysaccharidoses | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0085078 | Lysosomal Storage Diseases | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0524851 | Neurodegenerative Disorders | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0282160 | Aplasia Cutis Congenita | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C1561643 | Chronic Kidney Diseases | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0268731 | Renal glomerular disease | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C4225306 | CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2V | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0020295 | Hydronephrosis | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0205700 | Asymmetric Septal Hypertrophy | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
C0700095 | Central neuroblastoma | NAGLU | 4669 | N-acetyl-alpha-glucosaminidase | P54802 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024